Upgrade to SI Premium - Free Trial

Edwards Lifesciences (EW) PT Lowered to $85 at Canaccord

April 24, 2026 4:14 AM
Canaccord analyst William Plovanic lowered the price target on Edwards Lifesciences (NYSE: EW) to $85.00 (from $87.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change